메뉴 건너뛰기




Volumn 351, Issue , 2015, Pages

Restoring Study 329: Eficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; PAROXETINE; PLACEBO; ADRENERGIC RECEPTOR AFFECTING AGENT; ANTIDEPRESSANT AGENT;

EID: 84945899614     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h4320     Document Type: Article
Times cited : (244)

References (29)
  • 1
    • 84879364075 scopus 로고    scopus 로고
    • Restoring invisible and abandoned trials: A call for people to publish the findings
    • Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013;346:f2865.
    • (2013) BMJ , vol.346
    • Doshi, P.1    Dickersin, K.2    Healy, D.3    Vedula, S.S.4    Jefferson, T.5
  • 2
    • 0034961468 scopus 로고    scopus 로고
    • Eficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial
    • Keller MB, Ryan ND, Strober M, et al. Eficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
    • (2001) J Am Acad Child Adolesc Psychiatry , vol.40 , pp. 762-772
    • Keller, M.B.1    Ryan, N.D.2    Strober, M.3
  • 3
    • 55449116862 scopus 로고    scopus 로고
    • Industry-sponsored ghostwriting in clinical trial reporting: A case study
    • McHenry L, Jureidini J. Industry-sponsored ghostwriting in clinical trial reporting: a case study. Account Res 2008;15:152-67.
    • (2008) Account Res , vol.15 , pp. 152-167
    • McHenry, L.1    Jureidini, J.2
  • 4
    • 42149090567 scopus 로고    scopus 로고
    • Clinical trials and drug promotion: Selective reporting of study 329
    • Jureidini J, McHenry L, Mansfield P. Clinical trials and drug promotion: selective reporting of study 329. Int J Risk Saf Med 2008;20:73-81.
    • (2008) Int J Risk Saf Med , vol.20 , pp. 73-81
    • Jureidini, J.1    McHenry, L.2    Mansfield, P.3
  • 5
    • 79955081638 scopus 로고    scopus 로고
    • Conflicted medical journals and the failure of trust
    • Jureidini J, McHenry L. Conflicted medical journals and the failure of trust. Account Res 2011;18:45-54.
    • (2011) Account Res , vol.18 , pp. 45-54
    • Jureidini, J.1    McHenry, L.2
  • 6
  • 7
    • 84901006116 scopus 로고    scopus 로고
    • The CEA second-look trial: A randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer
    • May 13
    • Treasure T, Monson K, Fiorentino F, Russell C. The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer. BMJ Open 2014 May 13;4:e004385.
    • (2014) BMJ Open , vol.4
    • Treasure, T.1    Monson, K.2    Fiorentino, F.3    Russell, C.4
  • 8
    • 84907014634 scopus 로고    scopus 로고
    • Reanalyses of randomized clinical trial data
    • Ebrahim S, Sohani ZN, Montoya L, et al. Reanalyses of randomized clinical trial data. JAMA 2014;312:1024-32.
    • (2014) JAMA , vol.312 , pp. 1024-1032
    • Ebrahim, S.1    Sohani, Z.N.2    Montoya, L.3
  • 11
    • 84945908753 scopus 로고    scopus 로고
    • SAS Solutions OnDemand. www.ondemand.sas.com/sam/?sid=1393012805&rid=DqqHX0rCqAWZ7TJlCIPijRTscQ..
    • SAS Solutions OnDemand
  • 12
    • 85042394500 scopus 로고    scopus 로고
    • Rapid responses to putting GlaxoSmithKline to the test over paroxetine
    • Correspondence between Jureidini and GSK
    • Correspondence between Jureidini and GSK. Rapid responses to putting GlaxoSmithKline to the test over paroxetine. BMJ 2013;347:f6754. www.bmj.com/content/347/bmj.f6754/rapid-responses
    • (2013) BMJ , vol.347
  • 15
    • 0023549532 scopus 로고
    • Clinical management-imipramine/placebo administration manual. NIMH treatment of depression collaborative research program
    • Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH Clinical management-imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull 1987;23:309-24.
    • (1987) Psychopharmacol Bull , vol.23 , pp. 309-324
    • Fawcett, J.1    Epstein, P.2    Fiester, S.J.3    Elkin, I.4    Autry, J.H.5
  • 16
    • 0014186152 scopus 로고
    • Development of a rating scale for primary depressive illness
    • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
    • (1967) Br J Soc Clin Psychol , vol.6 , pp. 278-296
    • Hamilton, M.1
  • 17
    • 0024257663 scopus 로고
    • The measurement of behavioral autonomy in adolescence: The autonomous functioning checklist
    • Sigafoos AD, Feinstein CB, Damond M, Reiss D. The measurement of behavioral autonomy in adolescence: the Autonomous Functioning Checklist. Adolesc Psychiatry 1988;15:432-62.
    • (1988) Adolesc Psychiatry , vol.15 , pp. 432-462
    • Sigafoos, A.D.1    Feinstein, C.B.2    Damond, M.3    Reiss, D.4
  • 21
    • 84904045332 scopus 로고    scopus 로고
    • Inadequacy of remote desktop interface for independent reanalysis of data from drug trials
    • Jureidini JN, Nardo JM Inadequacy of remote desktop interface for independent reanalysis of data from drug trials. BMJ 2014;349:g4353.
    • (2014) BMJ , vol.349
    • Jureidini, J.N.1    Nardo, J.M.2
  • 22
    • 0029072914 scopus 로고
    • Dystonias and dyskinesias of the jaw associated with the use of SSRIs
    • Fitzgerald K, Healy D. Dystonias and dyskinesias of the jaw associated with the use of SSRIs. Human Psychopharmacol 1995;10:215-20.
    • (1995) Human Psychopharmacol , vol.10 , pp. 215-220
    • Fitzgerald, K.1    Healy, D.2
  • 25
    • 84945934762 scopus 로고
    • Review and evaluation of clinical data. Original NDA 20-031. Paroxetine (Aropax). Efficacy review
    • Brecher M. Review and evaluation of clinical data. Original NDA 20-031. Paroxetine (Aropax). Efficacy review. SmithKline Beecham Pharmaceuticals, 1991.
    • (1991) SmithKline Beecham Pharmaceuticals
    • Brecher, M.1
  • 26
    • 84904262560 scopus 로고    scopus 로고
    • Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: A cross-sectional study
    • Hughes S, Cohen, D, Jaggi R. Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study. BMJ Open 2014;4:e005535.
    • (2014) BMJ Open , vol.4
    • Hughes, S.1    Cohen, D.2    Jaggi, R.3
  • 27
    • 84902176817 scopus 로고    scopus 로고
    • Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: Comparison of clinical study reports, trial registries, and publications
    • Maund E, Tendal B, Hróbjartsson A, et al. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications. BMJ 2014;348:g3510
    • (2014) BMJ , vol.348
    • Maund, E.1    Tendal, B.2    Hróbjartsson, A.3
  • 28
    • 0028362045 scopus 로고
    • Major depression in community adolescents: Age at onset, episode duration, and time to recurrence
    • Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 1994;33:809-18.
    • (1994) J Am Acad Child Adolesc Psychiatry , vol.33 , pp. 809-818
    • Lewinsohn, P.M.1    Clarke, G.N.2    Seeley, J.R.3    Rohde, P.4
  • 29
    • 33646799096 scopus 로고    scopus 로고
    • Prospective studies of adverse events related to antidepressant discontinuation
    • Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry 2006;67(suppl 4):14-21.
    • (2006) J Clin Psychiatry , vol.67 , pp. 14-21
    • Fava, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.